J&J’s Janssen acquires cancer-killing virus tech

J&J’s Janssen acquires cancer-killing virus tech

Source: 
Drug Delivery Business News
snippet: 

Johnson & Johnson‘s (NYSE:JNJJanssen Biotech said today that it agreed to acquire BeneVir Biopharm and its T-Stealth oncolytic virus platform.